Description

8-Methyl-8-Azabicyclo-3-Endo[3.2.1]Oct-3-Yl-1,4-Dihydro-2-Oxo-3(2H)-Quinazolinecarboxylic Acid Ester Hydrochloride is a high-purity pharmaceutical intermediate and research chemical of significant interest in medicinal chemistry. Its complex bicyclic structure makes it a valuable building block for the synthesis of novel therapeutic agents, particularly those targeting the central nervous system. This compound is essential for researchers and manufacturers in the pharmaceutical and biotechnology sectors developing next-generation drug candidates.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of active pharmaceutical ingredients (APIs) with potential neurological activity.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Reference Standard: Serves as an analytical standard for quality control and method development in pharmaceutical analysis.
• Biochemical Research: Investigated for its interaction with biological targets, such as receptors or enzymes, in preclinical studies.
• Process Development: Employed in the development and scale-up of synthetic routes for complex organic molecules.
• Academic Research: Utilized in university and institutional labs for advanced organic synthesis and heterocyclic chemistry projects.

Basic Information

Product Name	8-Methyl-8-Azabicyclo-3-Endo[3.2.1]Oct-3-Yl-1,4-Dihydro-2-Oxo-3(2H)-Quinazolinecarboxylic Acid Ester Hydrochloride
CAS No.	131780-47-7
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 1,4-dihydro-2-oxo-3(2H)-quinazolinecarboxylate hydrochloride; 8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 1,4-dihydro-2-oxo-3(2H)-quinazolinecarboxylate hydrochloride; 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl ester, 1,4-dihydro-2-oxo-3(2H)-quinazolinecarboxylic acid, hydrochloride; 131780-47-7; 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 1,4-dihydro-2-oxo-3-quinazolinecarboxylate hydrochloride; Quinazolinecarboxylic acid, 1,4-dihydro-2-oxo-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, hydrochloride
EINECS	Contact for details

Quality Control

Our 8-Methyl-8-Azabicyclo-3-Endo[3.2.1]Oct-3-Yl-1,4-Dihydro-2-Oxo-3(2H)-Quinazolinecarboxylic Acid Ester Hydrochloride is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research and development. Certificates of Analysis (COA) detailing batch-specific results are available upon request to support your quality assurance protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area. Due to its hygroscopic nature, the container should be kept tightly sealed in a dry environment to prevent moisture absorption. Recommended storage temperature is 2-8°C for long-term stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.